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Since 1987 we have observed a predominance of adenoeareinoma in patients 
undergoing esophagectomy because of carcinoma at our institution. To dis- 
cover whether this observation represented an actual change in the prevalence 
of adenocarcinoma, the Johns Hopkins Hospital pathology records were 
reviewed for the years 1959 to 1994. Overall, esophageal squamous cell 
carcinoma was the most common histologic type with 817 cases identified 
versus 284 cases of adenocarcinoma. The number of patients with squamous 
cell carcinoma rose slowly from 1959 to 1992 but since 1992 has decreased. 
Whereas adenocarcinoma was uncommon before 1978, its frequency has since 
increased markedly, exceeding that of squamous cell carcinoma in 1994. The 
number of patients with adenocarcinoma who underwent surgical resection 
has equaled or exceeded the number of those treated nonoperatively for all 
recorded years. Therefore the predominance of adenocarcinoma in patients 
undergoing esophageal resection for carcinoma appears to result from two 
factors: an overall increase in the prevalence of adenocarcinoma since 1978 
and an increased likelihood of resection for patients with these tumors. 
(J Thorac Cardiovasc Surg 1996;112:130-6) 
S ince 1987 we have observed a predominance of adenocarcinoma in patients undergoing esopha- 
geal resection because of carcinoma t our institu- 
tion. To discover whether this observation repre- 
sented an actual change in the prevalence of 
esophageal adenocarcinoma or whether it was a 
result of surgical selection bias, the Johns Hopkins 
Hospital surgical pathology records were reviewed 
over a study period that spanned four decades (1959 
through 1994) to determine both the yearly preva- 
lence and number of surgical resections in patients 
with esophageal squamous cell carcinoma (SCCA) 
and adenocarcinoma. 
Patients and methods 
The surgical pathology records were r viewed to iden- 
tify all patients in whom the pathologic diagnosis of primary 
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SCCA or adenocarcinoma w s made at the Johns Hopkins 
Hospital between 1959 and 1994. Patients with SCCA or 
adenocarcinoma that secondarily invaded the esophagus 
from a nonesophageal primary tumor and patients in whom 
the esophagus was involved with metastatic disease were 
excluded. Primary gastric adenocarcinoma was excluded. 
Eleven patients had undifferentiated sophageal carcinoma 
that was not classified as SCCA or adenocarcinoma and 
these were also excluded from this study. 
From the pathology report, age, sex, and whether the 
specimen was from a biopsy procedure or resection were 
recorded for each patient. Patient race was recorded from 
the pathology records through 1984, when this informa- 
tion was dropped from the pathology database. From 1985 
to 1992, patient race was obtained from the medical 
records. From 1992 to 1994, patient race was not re- 
corded. Each patient was counted only once. 
A patient in whom the tumor was diagnosed by biopsy 
and in whom no surgical resection was done was recorded 
in the biopsy (nonoperative) group. Multiple synchronous 
or metachronous biopsies of the same tumor were 
counted as one event. Alternatively, patients in whom the 
tumor was resected, or sampled for biopsy and resected, 
were recorded under a single event each in the resection 
(surgical therapy) group. Patients in whom the diagnosis 
of SCCA or adenocarcinoma w s made or reviewed at our 
institution and who received neoadjuvant chemoradiation 
therapy followed by esophageal resection and in whom no 
residual SCCA or adenocarcinoma w s identified in the 
resection specimen (complete histologic response) were 
included and recorded in the resection group under the 
cell type determined by pretherapy biopsy. The results 
were tabulated by year. 
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Fig. 1. Total number of patients with esophageal SCCA and adenocarcinoma by year. 
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Fig. 2. Yearly number of white and black male patients with esophageal SCCA. 
Resu l ts  
Between 1959 and 1994, 1101 cases of SCCA or 
adenocarcinoma were noted in the pathology 
records at the Johns Hopkins Hospital. There were 
817 patients with SCCA and 284 patients with 
adenocarcinoma. The number of patients with a 
diagnosis of SCCA and adenocarcinoma per year is 
shown in Fig. 1. Overall, SCCA was the most 
common cell type. The number of patients with 
SCCA slowly increased from 1959 to 1992 and then 
decreased from 1992 to 1994. Adenocarcinoma was 
uncommon before 1978. Beginning in 1978, the 
number of patients with adenocarcinoma increased 
sharply and in 1994 for the first time since 1959 the 
number of patients with adenocarcinoma exceeded 
that of patients with SCCA. 
The yearly prevalence of SCCA in white and black 
male patients is shown in Fig. 2. Between the years 
1959 and 1970, SCCA was more common in white 
male patients. This trend was reversed for the next 
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Fig. 3. Yearly number of white and black female patients with esophageal SCCA. 
20 ~- 
18 
14 
" 10 \ 
"6 
o 8 
6 
Year 
• White - - c~-  Black , 
Fig. 4. Yearly number of white and black male patients with esophageal adenocarcinoma. 
eight years (1970 through 1978) and subsequently, 
from 1978 to the present, the frequency of SCCA in 
white and black male patients was equal. The yearly 
number of white and black female patients with 
SCCA is shown in Fig. 3. During the first decade 
(1959 to 1969), SCCA was more common in white 
female patients. Between 1970 and 1982 the number 
of black female patients with SCCA equaled or 
exceeded that of white female patients, and from 
1983 to the present his trend was reversed with a 
sharp increase in the number of white women with 
SCCA. 
The yearly prevalence of adenocarcinoma in
white and black male patients is shown in Fig. 4. The 
number of white male patients with adenocarcinoma 
has equaled or exceeded that of black male patients 
in all years since 1959 except in 1974 (1 black man, 
0 white men). Beginning in 1978 and continuing to 
the present, the number of white male patients with 
adenocarcinoma h s risen sharply without any cor- 
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Fig. 5. Yearly number oftotal patients with SCCA treated with and without (biopsy) surgical resection. 
responding change in the number of black male 
patients observed. Adenocarcinoma in women was 
uncommon. The frequency of adenocarcinoma in 
white female patients was one for the years 1961, 
1963, 1976, 1982, and 1988 through 1990. The 
frequency of adenocarcinoma in black female pa- 
tients was two in 1987 and one for the years 1989 
and 1990. Although the numbers are small, there 
was an increase in the number of white and black 
female patients with adenocarcinoma after 1984. 
The yearly number of patients with SCCA who 
underwent biopsy (nonsurgical therapy) versus re- 
section (surgical therapy) is shown in Fig. 5. The 
number of patients with SCCA treated without 
resection equaled or exceeded the number of pa- 
tients treated with resection for all recorded years. 
The total number of resections for patients with 
SCCA was 225. In two years, 1962 and 1993, the 
biopsy and resection rates were equal, and in both of 
these two years the number of resections was com- 
paratively low. The shape of the two curves, from 
1968 to the present, was approximately the same. 
The yearly number of patients with adenocarci- 
noma who underwent biopsy (nonsurgical therapy) 
versus resection (surgical therapy) isshown in Fig. 6. 
The number of patients treated with and without 
resection was equal between 1959 and 1987. After 
1987, the number of patients undergoing resection 
exceeded the number of patients who underwent 
biopsy and were treated without operation. The 
total number of resections for patients with adeno- 
carcinoma was 170. 
Between March 1989 and April 1994, 45 patients 
with locoregional esophageal cancer (SCCA 12 pa- 
tients, adenocarcinoma 31 patients, undifferentiated 
2 patients) were treated with preoperative chemo- 
radiation followed by operation. These results have 
been previously reported. 1 
Discussion 
Since 1987 we have observed a predominance of 
• adenocarcinoma in patients undergoing esophageal 
resection for carcinoma t our institution. To dis- 
cover whether this observation represented an ac- 
tual change in the prevalence of esophageal deno- 
carcinoma or whether it was a result of surgical 
selection bias, the Johns Hopkins Hospital surgical 
pathology records were reviewed for the years 1959 
through 1994 to identify all patients in whom the 
pathologic diagnosis of primary esophageal SCCA 
or adenocarcinoma was made to determine the 
yearly prevalence and number of resections in pa- 
tients with esophageal SCCA and adenocarcinoma. 
The study design uses our institution as its own 
control, and interpretation of the data ssumes, we 
believe reasonably, that there has been no major 
change in the referral patterns or indications for 
esophageal resection at our institution during the 
study period and that all patients in whom a diag- 
nosis of esophagea! SCCA or adenocarcinoma is 
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Fig. 6. Yearly number of total patients with adenocarcinoma treated with and without (biopsy) surgical 
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made remain at our institution for subsequent ther- 
apy. 
Overall, SCCA was the most common cell type, 
with 817 cases identified versus 284 cases of adeno- 
carcinoma. However, the yearly prevalence and pa- 
tient characteristics of esophageal SCCA and ade- 
nocarcinoma have not remained stable (Fig. 1). The 
number of patients with SCCA rose slowly from 
1959 to 1992, but since 1992 the number has been 
decreasing. Whereas adenocarcinoma was uncom- 
mon before 1978, its frequency has dramatically 
increased since that time and its frequency exceeded 
that of SCCA in 1994 for the first time since 1959. 
Adenocarcinoma is a disease almost exclusively of 
white men (Fig. 4), although interestingly the in- 
crease in the prevalence of adenocarcinoma is also 
demonstrated in black and white women. 
The changes in the yearly frequency of esophageal 
SCCA and adenocarcinoma that we have noted 
appear to be representative of what is being ob- 
served nationally. National statistics from the Sur- 
veillance Epidemiology and End Results (SEER) 
database 2 show only a slight increase (from 3.0 to 3.5 
per 100,000) in age-adjusted mortality rates for all 
patients with esophageal carcinoma from 1973 
through 1991. On the other hand, the SEER data 
confirm that the distribution of esophageal SCCA 
and adenocarcinoma is changing. During the 4-year 
period 1978 to 1982, the histologic distribution of 
esophageal cancer was SCCA 72%, adenocarcinoma 
13%, and other 15%. By 1988 to 1991, SCCA had 
fallen to 56.4%, adenocarcinoma h d increased to 
28.4%, and other esophageal cancers remained sta- 
ble at 15.2%. Other single-institution studies show 
similar trends. Yang and Davis 3 demonstrated a 
74% increase between 1973 and 1982 in adenocar- 
cinoma in white men and only a 30% increase in 
SCCA in black men and women. Pera and associ- 
ates 4reported that the incidence of adenocarcinoma 
in Olmsted County, Minnesota, rose significantly 
from 1974 to 1989, during which time the incidence 
of SCCA fell. Blot and associates 5 howed that the 
incidence of adenocarcinoma of the esophagus and 
gastric cardia rose between 1976 and 1987 at a rate 
that exceeded that of skin melanoma, non- 
Hodgkin's lymphoma, and lung cancer, whereas the 
incidence of SCCA remained stable. An increase in 
esophageal denocarcinoma h s also been reported 
in the United Kingdom, 6 Sweden, 7 and Western 
Europe. s
The observed variation in the number of patients 
with SCCA most likely reflects changing alcohol 
consumption and cigarette use, which are both 
documented causative agents for this disease. Nu- 
merous risk factors for esophageal denocarcinoma 
have been proposed, including tobacco use, 913 alco- 
hol consumption, 9-11'13 dietary factors, 13 genetic 
tendency,14, 15socioeconomic status, and peptic ul- 
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cer disease. 1° However, none of these factors i  
sufficient o explain the dramatic increase in esoph- 
ageal adenocarcinoma noted since 1978. On the 
other hand, there is a documented association of 
Barrett's esophagus (BE) and esophageal denocar- 
cinoma. Exactly what aspect of gastroesophageal 
reflux or its therapy has led to an increase in 
BE-associated adenocarcinoma, however, remains 
unclear. Two explanations that have been proposed 
are genetic alterations 16' 17 and the intriguing hy- 
pothesis that the increasing prevalence of adenocar- 
cinoma may be iatrogenic in relation to the use of 
pharmaceutical gents that relax the lower esopha- 
geal sphincter, is The reported prevalence of BE in 
patients who undergo esophagectomy for adenocar- 
cinoma has remained stable. In two earlier reports 
from our institution, BE was found in 63% 19 and 
64% 2o of patients with resected adenocarcinoma. 
These figures are identical to those of the Mayo 
Clinic experience reported by Pera and associates. 4 
The number of patients with SCCA treated with- 
out surgical resection exceeded the number of those 
who underwent resection by as much as 24:1, except 
during the years 1962 and 1993 (Fig, 6). No change 
in referral patterns or surgical treatment practice 
can be identified that would account for this obser- 
vation. Cigarette smoking and alcohol consumption, 
related medical complications, and more advanced- 
staged tumors on presentation as a result of tumor 
location are possible explanations for the observed 
low resection rate in SCCA. From 1959 to 1992, the 
biopsy and resection rate curves generally remained 
parallel, suggesting that during that period there was 
little change in the treatment of patients with SCCA 
tumors. Since 1992, the ratio of nonoperative to 
operative therapy has approached 1:1. 
The numbers of patients with adenocarcinoma 
treated with and without resection have been equiv- 
alent between 1959 and 1987. Since that time, the 
number of patients undergoing resection has ex- 
ceeded that of patients treated nonoperatively. Tu- 
mor location (lower half of the esophagus), fewer 
medical complications related to smoking and 
drinking, and more favorable tumor staging because 
of the high proportion of patients with adenocarci- 
noma receiving medical care for reflux-related se- 
quelae are possible reasons for the high resection 
rate in patients with adenocarcinoma. Another pos- 
sible cause for the increased frequency of resections 
in patients with adenocarcinoma at our institution 
may have been our belief that BE with high-grade 
dysplasia is an indication for esophageal resection 
and reconstruction. Regardless of attempts to iden- 
tify early-stage tumors, locally advanced-stage dis- 
ease (American Joint Committee for Cancer stage 
III) continues to be the most common finding in 
patients undergoing resection for adenocarcino- 
ma. 2° 
The predominance of adenocarcinoma in patients 
undergoing esophageal resection for carcinoma, 
therefore, appears to result from two factors: an 
overall increase in the prevalence of adenocarci- 
noma since 1978 and an increased likelihood of 
resection in patients with these tumors. 
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